Protagonist Therapeutics CFO, Chief Medical Officer, and Director make share trades.
ByAinvest
Friday, Mar 27, 2026 7:38 pm ET1min read
PTGX--
Protagonist Therapeutics, Inc. (PTGX) announced that Ali Asif, Chief Financial Officer, sold 24,765 shares at $104.24 per share on March 26, 2026. He also purchased 19,500 shares at $19.19 per share and 5,265 shares at $12.17 per share on the same day. Meanwhile, MOLINA ARTURO MD, Chief Medical Officer, acquired 15,000 shares at $8.04 per share but sold an equal number at $104.79 per share. Additionally, Director SELICK HAROLD E purchased 24,000 shares at $12.88 per share but sold the same amount at $105 per share on March 26, 2026.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet